Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Labwire Inc. -- Ignore unavailable to you. Want to Upgrade?

To: im a survivor who wrote (1647)	8/27/2009 4:31:42 PM
From: Ernest K Brandt	1 Recommendation Respond to of 1698

Hey why you guys take this to Private messaging???????????

To: im a survivor who wrote (1647)	8/31/2009 11:52:44 AM
From: shortsinthesand	Respond to of 1698

Labwire Becomes an SEC Reporting Company Wed May 7, 2008 10:03am EDT HOUSTON, TX, May 07 (MARKET WIRE) -- Labwire, Inc. (PINKSHEETS: LBWR), a leading provider of employee screening solutions, canine security, and compliance surveillance services, is pleased to report that on April 14, 2008 Labwire (trading symbol: lbwr) became a reporting company with the U.S. Securities and Exchange Commission. As a result, the company will be filing with the SEC periodic reports containing up-to-date information about the company, and the company will be subject to additional requirements enhancing investor protection. The necessary steps are now being taken to have the company's common stock traded on the OTC-BB (Bulletin Board). Management is now interviewing market makers and upon completion of the selection process projects the move to OTC-BB trading in approximately six weeks. During this time, management is transitioning into the status of a full-reporting public company. "We are working with our auditors to complete the 2007 annual audit as well as a review of our books and financial activity for 2008. We are getting everything prepared so that we can commence filing our periodic reports," stated Marlin Williford, Labwire CFO. Dexter Morris, Labwire Chairman and CEO, offers the following business insight: "We are excited about being an SEC reporting company and the possibilities that it permits having our common stock traded on the OTC Bulletin Board. These have been two of our major objectives for some time and it is a management priority to bring this process to a successful conclusion as soon as possible. Business prospects continue to be bright and I look forward to sharing progress with our shareholders as our marketing efforts turn opportunities into new contracts and increased business with existing clients in the coming months. We are entering our busy cycle for business development and I am very excited about the opportunities we are seeing in the marketplace." reuters.com